145 related articles for article (PubMed ID: 37987705)
1. [Myxoinflammatory fibroblastic sarcoma of the lower limb].
Almakrami M; Pancsa T; Kuthi L; Sejben A
Orv Hetil; 2023 Oct; 164(41):1637-1641. PubMed ID: 37987705
[TBL] [Abstract][Full Text] [Related]
2. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
3. Myxoinflammatory Fibroblastic Sarcoma of the Parotid Gland: First Case Report and Literature Review.
Wei C; Yang X; Guo P; Chen X; Li C; Chen J; Zhou S
Front Med (Lausanne); 2022; 9():833822. PubMed ID: 35669919
[TBL] [Abstract][Full Text] [Related]
4. High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases.
Michal M; Kazakov DV; Hadravský L; Kinkor Z; Kuroda N; Michal M
Ann Diagn Pathol; 2015 Jun; 19(3):157-63. PubMed ID: 25886867
[TBL] [Abstract][Full Text] [Related]
5. Myxoinflammatory fibroblastic sarcoma of the face.
Gómez Martín C; Ortega MI; Aramburu JA; Fernández-Cañamaque JL
Am J Dermatopathol; 2012 Aug; 34(6):663-5. PubMed ID: 22814322
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
[TBL] [Abstract][Full Text] [Related]
7. An update on selected cutaneous (myo) fibroblastic mesenchymal tumors.
Georgantzoglou N; Linos K
Semin Diagn Pathol; 2023 Jul; 40(4):295-305. PubMed ID: 37150655
[TBL] [Abstract][Full Text] [Related]
8. Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?
Sparkman BK; Nguyen TVV; Smith SC; Bear HD
J Investig Med High Impact Case Rep; 2023; 11():23247096231205344. PubMed ID: 37840277
[TBL] [Abstract][Full Text] [Related]
9. Myxoinflammatory fibroblastic sarcoma of the scalp: aggressive behavior at a rare, nonextremity site.
Vroobel K; Miah A; Fisher C; Thway K
Int J Surg Pathol; 2015 Jun; 23(4):292-7. PubMed ID: 25673633
[TBL] [Abstract][Full Text] [Related]
10. Recurrent YAP1::MAML2 fusions in "nodular necrotizing" variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases.
Perret R; Tallegas M; Velasco V; Soubeyran I; Coindre JM; Azmani R; Baud J; Bacle G; De Pinieux G; Le Loarer F
Mod Pathol; 2022 Oct; 35(10):1398-1404. PubMed ID: 35546636
[TBL] [Abstract][Full Text] [Related]
11. Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet.
Meis-Kindblom JM; Kindblom LG
Am J Surg Pathol; 1998 Aug; 22(8):911-24. PubMed ID: 9706971
[TBL] [Abstract][Full Text] [Related]
12. Myxoinflammatory fibroblastic sarcoma: ultrastructural study of 7 cases.
Corredor-Alonso GE; Caro-Sánchez CHS; Domínguez-Malagón HR
Ultrastruct Pathol; 2024 Jan; 48(1):75-79. PubMed ID: 38126325
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity.
Michal M; Kazakov DV; Hadravský L; Agaimy A; Švajdler M; Kuroda N; Michal M
Ann Diagn Pathol; 2016 Feb; 20():40-3. PubMed ID: 26626209
[TBL] [Abstract][Full Text] [Related]
14. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature.
Wangsiricharoen S; Ali SZ; Wakely PE
J Am Soc Cytopathol; 2021; 10(3):310-320. PubMed ID: 33431307
[TBL] [Abstract][Full Text] [Related]
15. Myxoinflammatory fibroblastic sarcoma: report of a case and review of the literature.
Alaggio R; Coffin CM; Dall'igna P; Bisogno G; Olivotto A; Di Venosa B; Fassina A
Pediatr Dev Pathol; 2012; 15(3):254-8. PubMed ID: 22372507
[TBL] [Abstract][Full Text] [Related]
16. Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation.
Hallin M; Miki Y; Hayes AJ; Jones RL; Fisher C; Thway K
Rare Tumors; 2018; 10():2036361318782626. PubMed ID: 29977483
[TBL] [Abstract][Full Text] [Related]
17. The first case of myxoinflammatory fibroblastic sarcoma affecting the maxillary bone.
Boran Ç; Kilitci A; Ahsen H; Yılmaz F
Int J Health Sci (Qassim); 2022; 16(2):37-39. PubMed ID: 35300266
[TBL] [Abstract][Full Text] [Related]
18. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
19. The t(1;10)(p22;q24) TGFBR3/MGEA5 Translocation in Pleomorphic Hyalinizing Angiectatic Tumor, Myxoinflammatory Fibroblastic Sarcoma, and Hemosiderotic Fibrolipomatous Tumor.
Liu H; Sukov WR; Ro JY
Arch Pathol Lab Med; 2019 Feb; 143(2):212-221. PubMed ID: 29979612
[TBL] [Abstract][Full Text] [Related]
20. Myxoinflammatory Fibroblastic Sarcoma.
Wu H; Laskin WB
Surg Pathol Clin; 2024 Mar; 17(1):83-96. PubMed ID: 38278610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
